drugset / Trial / NCT00002533

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

NCT00002533

Phase 2/3 Completed University of Miami
RandomizedTreatment

Summary

RATIONALE: Giving fluconazole may be effective in preventing or controlling mucositis caused by radiation therapy to the head and neck. PURPOSE: Randomized phase II/III trial to study the effectiveness of fluconazole in preventing mucositis in patients undergoing radiation therapy for head and neck cancer.

Timeline

Start
1993-02
Primary completion
2006-06
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule Oral